Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats

Ahmed HI, Abdel-Sattar SA, Zaky HS (2018) Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway. Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-018-1552-y

Article  PubMed  Google Scholar 

Beutler E, Duron O, Kelly BM (1963) Beutler E, Duron 0 & Kelly B M. Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888

CAS  PubMed  Google Scholar 

Bian SZ, Liu WL, Zhang ZX et al (2009) The correlation between ketamine-induced schizophrenia-like signs in mice and the expressions of NRG1, ErbB4 mRNA. J Forensic Med. https://doi.org/10.3969/j.issn.1004-5619.2009.05.009

Article  Google Scholar 

Bolton MM, Heaney CF, Sabbagh JJ et al (2012) Deficits in emotional learning and memory in an animal model of schizophrenia. Behav Brain Res. https://doi.org/10.1016/j.bbr.2012.04.049

Article  PubMed  PubMed Central  Google Scholar 

Bouayed J, Rammal H, Soulimani R (2009) Oxidative stress and anxiety relationship and cellular pathways. Oxid Med Cell Longev 2(2):63–7

Article  Google Scholar 

Boultadakis A, Pitsikas N (2010) Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat. Neuropsychopharmacology. https://doi.org/10.1038/npp.2010.109

Article  PubMed  PubMed Central  Google Scholar 

Buonanno A (2010) The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits. Brain Res Bull 83(3–4):122–131

CAS  Article  Google Scholar 

Carli M, Calcagno E, Mainolfi P et al (2011) Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: Relationship with glutamate release in the medial prefrontal cortex. Psychopharmacology. https://doi.org/10.1007/s00213-010-2065-7

Article  PubMed  Google Scholar 

Cavoy A, Delacour J (1993) Spatial but not object recognition is impaired by aging in rats. Physiol Behav. https://doi.org/10.1016/0031-9384(93)90148-9

Article  PubMed  Google Scholar 

Chadha R, Meador-Woodruff JH (2020) Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia. Neuropsychopharmacol 45:1059–1067. https://doi.org/10.1038/s41386-020-0614-2

CAS  Article  Google Scholar 

Chatterjee M, Ganguly S, Srivastava M, Palit G (2011) Effect of ‘chronic’ versus ‘acute’ ketamine administration and its ‘withdrawal’ effect on behavioural alterations in mice: Implications for experimental psychosis. Behav Brain Res. https://doi.org/10.1016/j.bbr.2010.08.001

Article  PubMed  Google Scholar 

Chatterjee M, Verma R, Kumari R et al (2015) Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems. Pharm Biol. https://doi.org/10.3109/13880209.2014.976350

Article  PubMed  Google Scholar 

Che Y, Wang JF, Shao L, Young LT (2010) Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci 35(5):296–302

Article  Google Scholar 

Chindo BA, Adzu B, Yahaya TA, Gamaniel KS (2012) Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia. Prog Neuro-Psychopharmacology Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2012.04.018

Article  Google Scholar 

Chong VZ, Thompson M, Beltaifa S et al (2008) Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res. https://doi.org/10.1016/j.schres.2007.12.474

Article  PubMed  PubMed Central  Google Scholar 

Chung DW, Chung Y, Bazmi HH, Lewis DA (2018) Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders. Neuropsychopharmacology. https://doi.org/10.1038/s41386-018-0169-7

Article  PubMed  PubMed Central  Google Scholar 

de Oliveira L, Cecília CM, Bortolin T et al (2009) Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuro-Psychopharmacol Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2009.05.010

Article  Google Scholar 

Deakin IH, Law AJ, Oliver PL et al (2009) Behavioural characterization of neuregulin 1 type i overexpressing transgenic mice. NeuroReport. https://doi.org/10.1097/WNR.0b013e328330f6e7

Article  PubMed  PubMed Central  Google Scholar 

Dejaegere T, Serneels L, Schäfer MK et al (2008) Deficiency of Aph1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.0800507105

Article  PubMed  PubMed Central  Google Scholar 

delPino I, García-Frigola C, Dehorter N et al (2013) Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron. https://doi.org/10.1016/j.neuron.2013.07.010

Article  Google Scholar 

El Iskandrani KS, Oosterhof CA, El Mansari M, Blier P (2015) Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: an in vivo electrophysiological study on monoaminergic and glutamatergic neurons. J Psychopharmacol. https://doi.org/10.1177/0269881115573809

Article  PubMed  PubMed Central  Google Scholar 

Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res. https://doi.org/10.1016/0166-4328(88)90157-X

Article  PubMed  Google Scholar 

Enriquez-Barreto L, Morales M (2016) The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia. Mol and Cell Ther 4:2. https://doi.org/10.1186/s40591-016-0047-9

Article  Google Scholar 

Fortin DA, Srivastava T, Soderling TR (2012) Structural modulation of dendritic spines during synaptic plasticity. Neuroscientist 18(4):326–341

Article  Google Scholar 

Gama CS, Canever L, Panizzutti B et al (2012) Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophr Res. https://doi.org/10.1016/j.schres.2012.08.002

Article  PubMed  Google Scholar 

Georgiadou G, Grivas V, Tarantilis PA, Pitsikas N (2014) Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats. Psychopharmacology (Berl). https://doi.org/10.1007/s00213-013-3293-4

Article  Google Scholar 

Glausier JR, Fish KN, Lewis DA (2014) Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry. https://doi.org/10.1038/mp.2013.152

Article  PubMed  Google Scholar 

Grieco SF, Qiao X, Johnston KG et al (2021) Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine. Transl Psychiatry. https://doi.org/10.1038/s41398-021-01255-4

Article  PubMed  PubMed Central  Google Scholar 

Gu Z, Jiang Q, Fu AKY et al (2005) Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci. https://doi.org/10.1523/JNEUROSCI.1086-05.2005

Article  PubMed  PubMed Central  Google Scholar 

Gupta S, Masand P (2004) Aripiprazole: Review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry. https://doi.org/10.1080/10401230490487007

Article  PubMed  Google Scholar 

Hahn CG, Wang HY, Cho DS et al (2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. https://doi.org/10.1038/nm1418

Article  PubMed  Google Scholar 

Harvey PD, Keefe RSE (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158(2):176–184

CAS  Article  Google Scholar 

Hasan A, Roeh A, Leucht S et al (2020) Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial. Contemp Clin Trials Commun. https://doi.org/10.1016/j.conctc.2020.100537

Article  PubMed  PubMed Central  Google Scholar 

Hashimoto R, Straub RE, Weickert CS et al (2004) Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry. https://doi.org/10.1038/sj.mp.4001434

Article  PubMed  Google Scholar 

Hereta M, Kamińska K, Białoń M et al (2020) Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex. Behav Brain Res. https://doi.org/10.1016/j.bbr.2020.112769

Article  PubMed  Google Scholar 

Hoftman GD, Volk DW, Bazmi HH et al (2015) Altered cortical expression of GABA-related genes in schizophrenia: Illness progression vs developmental disturbance. Schizophr Bull. https://doi.org/10.1093/schbul/sbt178

Article  PubMed  Google Scholar 

Hongyan L, Chunyan W, Yue’e Y, (2017) LY294002, a PI3K inhibitor, attenuates Tourette syndrome in rats. Metab Brain Dis. https://doi.org/10.1007/s11011-017-0051-z

Article  PubMed  Google Scholar 

Hou Y, Xie J, Yuan Y et al (2020) Neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia. Nord J Psychiatry. https://doi.org/10.1080/08039488.2020.1771767

Article  PubMed  Google Scholar 

Ibrahim WW, Sayed RH, Kandil EA, Wadie W (2022) Niacin mitigates blood–brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: role of GPR109A receptor. Prog Neuro-Psychopharmacology Biol Psychiatry 119:110583. https://doi.org/10.1016/j.pnpbp.2022.110583

CAS  Article  Google Scholar 

Idris N, Neill J, Grayson B et al (2010) Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacology 208:23–36. https://doi.org/10.1007/s00213-009-1702-5

CAS  Article  PubMed  Google Scholar 

Janardhanan A, Sadanand A, Vanisree AJ (2017) Nardostachys jatamansi Targets BDNF-TrkB to Alleviate Ketamine-Induced Schizophrenia-Like Symptoms in Rats. Neuropsychobiology. https://doi.org/10.1159/000454985

Article  Google Scholar 

Kandratavicius L, Balista PA, Wolf DC et al (2015) Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia. BMC Neurosci. https://doi.org/10.1186/s12868-015-0149-3

Article 

留言 (0)

沒有登入
gif